BioMimetix_LOGO-

BioMimetix Pharmaceutical, Inc.

BioMimetix is developing a novel therapeutic class of redox active metalloporphyrin compounds capable of treating a wide range of inflammatory diseases.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.biomimetixpharma.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
5350 South Roslyn Street Suite 430, CO 080111
Greenwood Village
United States
Email
Contact Number
+1 303 882 7027

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/biomimetix” connections=”true” suffix=””]